REDIRECTING ENGINEERED T CELLS USING A SMALL MOLECULE DRUG: A NOVEL APPROACH FOR THE TREATMENT OF METASTATIC PROSTATE CANCER
$307,632FY2015Department of DefenseDOD
California Institute For Biomedical Research, The
California Institute For Biomedical Research, The